Bravida (BRAV) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
17 Nov, 2025Executive summary
Q1 2025 net sales declined 5% year-over-year to SEK 6.888 billion, mainly due to selective project intake and a challenging market, with negative organic growth offset by acquisitions and currency effects.
EBITA/EBITDA increased to SEK 307 million, with margin improvement to 4.5% from 4.0% year-over-year, and all countries showing margin gains.
Order backlog grew by SEK 658 million, with increases in Norway, Denmark, and Finland, but a decline in Sweden; order intake stable overall.
Service business remains stable, representing close to 50% of revenue, while installation business faces ongoing challenges and regional disparities.
Strong cash flow and balance sheet, with net debt/EBITDA at 1.0x and cash conversion at 101–201%.
Financial highlights
Net sales: SEK 6,888 million (down 5% year-over-year); organic growth -6%, acquisitions +2%, currency -1%.
EBITA/EBITDA: SEK 307 million (up 4% year-over-year); margin 4.5% (up from 4.0%).
Operating cash flow: SEK 280 million, impacted by higher tax payments.
Cash and cash equivalents at SEK 608 million; net debt at SEK 2,156 million.
Cash conversion reached 101–201%, up from 90% last year.
Outlook and guidance
Service activity expected to remain stable; installation market faces ongoing challenges with regional variation.
Management expects 2025 to be difficult but believes the market has bottomed out, with easier comparisons ahead and brighter outlook for 2026–2027.
Margin improvement prioritized over volume growth; project selectivity and cost control to continue.
Full-year EBITDA margin in Denmark expected to approach or slightly exceed 5%; stable or slightly improved margins anticipated in Sweden.
External forecasts predict 4–6% installation volume growth in the Nordics for 2025–2026, with Sweden lagging.
Latest events from Bravida
- EBITA margin and EPS rose in Q4, with strong cash flow and order intake despite lower sales.BRAV
Q4 202518 Feb 2026 - EBITA down 17% on flat sales, but cash flow and service growth offset installation weakness.BRAV
Q3 202418 Feb 2026 - Flat sales, improved margins, strong cash flow, and higher dividend despite market headwinds.BRAV
Q4 202418 Feb 2026 - Q2 sales up 5%, margin down to 4.5%, but cash flow and backlog strong; margin recovery expected.BRAV
Q2 20243 Feb 2026 - EBITA margin rose to 5.4% and order intake increased 9% despite a 9% sales decline.BRAV
Q2 202513 Nov 2025 - EBITA margin rose to 5.3% and EPS increased 24% despite lower sales and challenging markets.BRAV
Q3 202524 Oct 2025